Healthcare systems across Asia-Pacific, including Malaysia, are facing rising costs, ageing populations and increasingly complex patient needs.
As healthcare systems shift from paying primarily for healthcare activity towards focusing on patient outcomes, hospitals are being asked to look beyond whether a treatment was delivered and assess whether patients recover safely, regain function and experience a better quality of life.
In this exclusive interview with PP Health Malaysia (PPHM), Adjunct Associate Professor Dr Keith Lim, Group Chief Medical Officer of IHH Healthcare, discusses what the shift towards outcomes-focused care means for hospitals, clinicians, payers and patients.
He also explains the infrastructure required to measure outcomes, the safeguards needed before hospitals assume greater financial responsibility and the role of credible health reporting in helping patients make informed decisions.
Treatment delivered is no longer the only measure of success
In practical terms, the question is no longer simply, “Was the treatment delivered?”, but also “Did the patient recover well, avoid preventable complications, regain function and experience a better quality of life?”
For hospitals, this means measuring outcomes consistently, using evidence-based clinical pathways and bringing multidisciplinary teams together to improve the patient journey. It also means considering the resources used to achieve these outcomes, so that quality and efficiency improve together.
IHH’s Value-Driven Outcomes (VDO) framework puts this into practice by measuring clinical performance against international benchmarks.
In Malaysia, IHH’s colonoscopy programme recorded a polyp detection rate of 50%, compared with an international benchmark of 40%.
For total knee replacement, patient-reported outcome scores improved by 41 points at three months and 52 points at six months after surgery. This exceeded the international Minimal Clinical Importance Difference standard of 11.1 points.
“For patients, the goal is safer, more coordinated care focused on recovery, function and quality of life, rather than the procedure alone,” Dr Lim said.
Measurement, implementation and alignment remain barriers
Bain & Company’s 2026 Asia-Pacific research found that more than half of surveyed doctors were more interested in payment models linked to patient outcomes than they were two years earlier. However, fewer than one-third said their hospitals had implemented them.
Lim said the main barriers fell into three areas: measurement, implementation and alignment.
The first is measurement. Providers need consistent data, agreed definitions of success and appropriate adjustment for patient complexity and clinical risk.
“Without these, performance cannot be assessed fairly,” he said.
The second barrier is implementation. Information systems, financing arrangements, clinical processes and data maturity vary considerably across Asia-Pacific markets.
The third is alignment. Clinicians, hospitals and payers must agree on what will be assessed, who is responsible for each part of the patient journey and how financial risk will be shared.
“Bain & Company’s 2026 Asia-Pacific research found that more than half of surveyed doctors were more interested in payment models linked to patient outcomes than they were two years earlier. However, fewer than one-third said their hospitals had implemented them”
IHH Malaysia’s VDO framework demonstrates the importance of building these foundations. Tracking procedures such as colonoscopy and total knee replacement against international benchmarks gives clinicians a structured approach to evaluate performance and strengthen care delivery.
“These foundations must be established before payment is linked to outcomes,” Dr Lim said.
“Otherwise, providers may be assessed unfairly and financial incentives may not lead to better care.”
Five foundations needed before hospitals assume greater financial responsibility
Before assuming greater financial responsibility for patient outcomes, hospitals need five foundations: evidence-based clinical pathways, clinically meaningful measures, reliable data systems, appropriate risk adjustment and strong clinical governance.
Hospitals must be able to review variations in performance, investigate adverse results, implement improvements and monitor whether those changes are delivering better outcomes over time.
IHH’s VDO framework illustrates the type of infrastructure that is needed by tracking clinical performance against international benchmarks. In Malaysia, this includes colonoscopy detection rates and patient-reported outcomes following total knee replacement.
“These measures help clinical teams assess results and identify where improvements may be needed,” Dr Lim said.
Providers and payers must also agree transparently on how outcomes will be measured, how patient risk will be accounted for and how safety and access will be protected.
“A hospital should assume outcome-linked financial responsibility only when its data, measurement systems and governance processes are robust enough to support fair and reliable decisions,” Dr Lim told PPHM.
Shared standards, with room for clinical judgement
From a Group medical perspective, a large hospital network needs shared Group-wide standards and clear governance, while retaining room for clinical judgement.
At IHH, evidence-based standards, quality indicators, risk monitoring and audits operate at hospital, country and Group levels.
“Shared standards do not mean every patient receives identical care. Doctors must still adapt treatment to the patient’s condition, clinical risk, preferences and response to treatment”
This allows performance to be reviewed consistently and gives patients confidence that, wherever they seek care within the IHH network, they can expect the same high standards of quality and patient safety.
However, shared standards do not mean every patient receives identical care. Doctors must still adapt treatment to the patient’s condition, clinical risk, preferences and response to treatment.
Benchmarking also helps clinicians understand how their results compare with established standards and where further review may be required. Effective practices can then be shared with other hospitals and adapted to their settings.
An example recognised at the IHH Quality Summit 2026 was Mount Elizabeth Novena Hospital’s initiative to reduce perioperative skin injuries.
The rate fell from 0.74 per 1,000 surgeries to zero. The approach was subsequently adopted across IHH hospitals in Singapore.
Data must lead to changes in everyday practice
Hospitals are collecting increasing amounts of clinical data, but measurement alone does not necessarily improve care.
“Data creates value when it informs clinical decisions or changes in how care is delivered,” Dr Lim said.
Hospitals need structured processes to review findings, understand variations, agree on practical improvements and assess whether those measures lead to better outcomes.
This requires clinical leadership and multidisciplinary collaboration. Doctors, nurses, allied health professionals and operational teams see different parts of a patient’s journey.
“Bringing these perspectives together can uncover delays, reduce risks and prevent avoidable complications,” he said.
There must also be clear accountability for taking action and reviewing its impact. Data should not simply be collected for reporting purposes. It should help teams identify what needs to change, implement the change and determine whether it has worked.
At Gleneagles Hospital Johor, an enhanced recovery pathway for colorectal surgery reduced average hospital stay from 10 days to five, with zero readmissions and zero surgical site infections recorded.
Separately, at Premier Integrated Rehab, a digital workflow implemented across 15 rehabilitation centres reduced the time spent processing daily census data from 420 minutes to six minutes. This allowed teams to spend less time on administration.
“The impact can be clinical or operational,” Dr Lim said.
Clinical and patient-reported outcomes must be considered together
Diagnosis-Related Group (DRG) payment and other payment reforms may improve cost predictability, but they do not automatically show whether a patient has recovered well.
Providers and payers need a balanced set of measures that reflects clinical effectiveness, patient experience and the resources required to deliver care.
Clinical measures may include complications, readmissions and infection rates. Patient-reported measures can capture pain, functional recovery and quality of life.
Resource-use measures, such as length of stay, are also relevant, but should be considered alongside clinical outcomes rather than in isolation.
Patient feedback is particularly valuable because a procedure can be technically successful while the individual continues to experience pain or difficulty with daily activities.
“This helps clinicians understand whether treatment has delivered a meaningful improvement,” Dr Lim said.
IHH Malaysia’s total knee replacement programme illustrates this approach. Patient-reported outcome scores improved by 41 points at three months and 52 points at six months after surgery, surpassing the international Minimal Clinical Importance Difference standard of 11.1 points.
For colonoscopy, detection rates provide another example of a procedure-specific measure used to assess clinical performance.
“No single indicator can fully describe value across every clinical setting,” Dr Lim said.
“Cost predictability and shorter hospital stays are important considerations, but they do not by themselves demonstrate if care has been effective.”
Payment models need safeguards against undertreatment
Outcome-linked payment models must be designed carefully to improve affordability without encouraging providers to undertreat patients, discharge them too early or avoid people with more complex or higher-risk conditions.
“The design of the payment model is critical,” Dr Lim said.
“It should not depend on a single outcome or reward providers simply for reducing the amount of care delivered.”
Four safeguards are essential.
First, payments must be adjusted for patient complexity so that providers are not penalised for treating people with more challenging conditions.
Second, assessment should cover complications, readmissions, functional recovery and patient experience, rather than cost alone.
“The purpose of payment reform is to support better care and more responsible use of resources, not to create a financial reason to withhold necessary treatment“
Third, monitoring and clinical oversight are needed to detect undertreatment or premature discharge.
Finally, patient access must be tracked to identify whether higher-risk individuals are being excluded.
Clinical judgement must remain central.
“The purpose of payment reform is to support better care and more responsible use of resources, not to create a financial reason to withhold necessary treatment,” Dr Lim said.
Lessons must be adapted to local conditions
Healthcare systems across Asia-Pacific differ in their data infrastructure, financing arrangements, provider capacity and patient populations.
Dr Lim said the starting point should be to understand the clinical problem and the local context, rather than assuming that an intervention will produce the same results everywhere.
Differences in patient populations, healthcare resources, regulations and financing arrangements all influence how an approach should be adapted.
A large hospital network can support this process by sharing evidence, practical experience and lessons from different hospitals. Common clinical standards and outcome measures make it easier to identify promising approaches, while local clinical teams can assess whether an intervention is appropriate and what adjustments may be needed.
IHH’s clinical governance framework provides Group-level oversight while retaining hospital- and country-level accountability.
This allows clinical performance to be reviewed against shared standards while recognising the need for local judgement and decision-making.
“It is also important to understand why an intervention worked in its original setting,” Dr Lim said.
“Workforce capabilities, available resources and clinical processes may all influence the outcome.”
When an approach is introduced elsewhere, its impact should continue to be monitored and evaluated.
“The objective is not to replicate every process identically across markets, but to apply evidence and shared learning responsibly,” he said.
“We should standardise the evidence and principles, while localising the implementation.”
Smaller clinics require support and proportionate measures
Smaller clinics may not have the same financial resources, technology or administrative capacity as large hospital groups.
Any model needs to reflect the resources and capabilities of the providers expected to participate.
Smaller clinics may require practical support with data collection, digital systems, staff training and outcome measurement, rather than being expected to build these capabilities independently.
Measures should also be proportionate to the type of care delivered.
“A clinic providing primary care should not be assessed using the same indicators as a tertiary hospital performing complex surgery,” Dr Lim said.
Safeguards are equally important. Payment arrangements should not create incentives to turn away patients with complex conditions or greater healthcare needs.
This requires transparent criteria, appropriate risk adjustment and monitoring of both care quality and patient access.
Collaboration between hospitals, clinics, payers and policymakers can help develop the data and governance capabilities needed over time.
Transition arrangements are also important, so that smaller providers are not exposed to excessive financial risk before their systems and processes are sufficiently mature.
Patients need clear explanations about DRGs and outcome-based payment
Most patients are unlikely to be familiar with DRGs or outcome-based payment, but may worry that reform means reduced treatment or higher out-of-pocket costs.
The public does not need to understand every technical detail of DRGs or outcome-based payment. However, patients should know that treatment decisions must continue to be guided by clinical need, evidence and an informed discussion of benefits, risks, alternatives and costs.
Credible health reporting such as this can help the public distinguish genuine improvements from incomplete claims and misinformation.
“A shorter hospital stay, for example, is not necessarily a better outcome unless it is accompanied by safe recovery, acceptable complication and readmission rates, and good patient-reported outcomes,” Dr Lim said.
Credible and trusted, evidenced-based health news site including PP Health Malaysia (PPHM) can help by explaining the evidence in accessible language, examining both the benefits and risks of reform, and giving patients practical questions to ask about expected recovery, quality, alternatives and costs.
Patients may ask:
- What outcome is this treatment intended to achieve?
- How long is recovery expected to take?
- What complications or warning signs should I look out for?
- What alternatives are available?
- What will the treatment and follow-up cost?
- What happens if my recovery does not proceed as expected?
- How will my care be coordinated after discharge?
- Which results or quality measures are used to assess this service?
“At IHH, outcome measurement helps us assess care from multiple perspectives, including clinical results and patient-reported recovery,” Dr Lim said.
“The broader objective is to make healthcare quality easier to understand and support more informed conversations between patients and their care teams.”
What patients should notice in the next three to five years
If healthcare systems across Asia-Pacific successfully move towards more outcomes-focused care over the next three to five years, patients should notice clearer information about what recovery should look like, more consistent care pathways and better coordination between care teams.
They should also experience greater transparency about quality and expected outcomes, together with fewer avoidable complications or gaps in follow-up.
Patients should have a stronger voice in defining success.
“For many people, success is not simply surviving a procedure or leaving hospital sooner,” Dr Lim said.
“It is being able to walk, work, sleep, live independently or return to the activities that matter to them.”
Affordability is an important part of this transition, but success cannot be defined by lower expenditure alone.
“It must be demonstrated through safer care, meaningful recovery, fair access and outcomes that patients can understand and experience,” Dr Lim said.
About Adjunct Associate Professor Dr Keith Lim
As Group Chief Medical Officer at IHH Healthcare, Adjunct Associate Professor Keith Lim oversees clinical quality, patient safety and value-based care across the group. He sets policies and drives quality improvements to help ensure patients receive world-class and cost-effective care.
With more than 20 years of experience as a radiation oncologist, Lim has also made significant academic contributions. He previously served as Assistant Dean at the NUS School of Medicine. His research has been cited more than 2,000 times, and he has secured more than S$2.5 million in research funding.
Before joining IHH, Lim was Group Chief Value Officer at NUHS, where he pioneered Singapore’s value-based healthcare programme and led efforts to optimise clinical and financial outcomes.
He also served as Director of Clinical Outcomes and Value at Singapore’s Ministry of Health, where he set clinical standards and implemented value-driven care across public hospitals.
His contributions have earned him Singapore’s National Medical Excellence Award, the country’s highest medical honour.
























